Andi Haswidi
As the head of ASEAN Research, Andi focuses on anchoring research reports and writing data-led stories at DealStreetAsia. He is an accomplished researcher, journalist and author. His first book, KOPI: Indonesian Coffee Craft & Culture, was published in 2018.
Stories by Andi Haswidi
Data Vantage: DayaTani, Noomoo, Ketomei, PDAX and Mighty Bear report updates
Indonesian agritech firm DayaTani added Northstar Ventures, BRI Ventures and Gentree Fund to its cap table this week.
Data Vantage: DigiAsia, InCorp, Box Vietnam, Paper.id and Alodokter report updates
Indonesian fintech firm DigiAsia Bios issued new shares to existing shareholders and new investors last week.
Data Vantage: Mesh Bio, Komunal, UNOAsia and OPAL Payment file updates
Healthtech company Mesh Bio has issued new shares as part of a recently announced Series A round.
Data Vantage: Funding Societies, Finn, Lifepal, SCI Ecommerce and Buymed report updates
Funding Societies received capital from Malaysian sovereign wealth fund Khazanah and fintech firm CGC Digital last week.
Data Vantage: Blue Planet, Rario, Nuguru, Arival and Lyte Ventures report updates
Blue Planet plans to acquire an e-waste recycling firm in India with its recently secured financing.
SE Asia climate tech startups charge ahead, but not immune to funding woes
SE Asian climate tech startups clocked more deals in Jan-Nov 2023 than in the whole of last year.
Data Vantage: ImmunoScape, ProfilePrint, EDPR APAC and BuyStars rake in capital
ImmunoScape, a biotech company focusing on next-generation immunotherapies, has issued new preference shares.
Data Vantage: Biobot, Meatiply, Get, 1 Play Sports and Web3Auth raise capital
Biobot Surgical is a Singapore-based company developing robotic diagnostic solutions.
Data Vantage: Nitex, Laku6, Web3Auth and LionsBot report cap table updates
Apparel and fashion commerce platform Nitex issued new shares last week to a group of investors.
Deep tech sustains healthtech dealmaking momentum in SE Asia
The healthtech sector has defied the wider dealmaking slowdown in the first nine months of 2023.
